Clinical significance of 18F-FDG PET/CT evaluation of response to treatment in T-cell lymophoma

Juan CHENG,Xiao-yi YANG,Wen-gui XU,Xiu-yu SONG,Dong DAI,Yan-jia ZHU

DOI: https://doi.org/10.3760/cma.j.issn.0253-2727.2012.01.004

2012-01-01

Abstract:Objective To investigate the usefulness of 18F-FDG PET/CT imaging in restaging,evaluating the treatment outcome,monitoring relapse and predicting prognosis of T-cell lymphoma.Methods Retrospective analysis of PET/CT image results of thirty-four patients with T-cell lymphoma,and to evaluate its clinical significance in restaging,treatment efficiency,relapse monitor and progrosis prediction.Results Clinical restaging among the 20 stage Ⅰ and Ⅱ patients,6 were ascended,9 descended and 5 unchanged.Restaging among the other 14 stage Ⅲ and Ⅳ patients,3 were ascended,4 descended and 7 unchanged.There were 12 patients in complete remission( CR),11 in partial remission( PR),2 in stable disease(SD)and 9 in progressive disease (PD) among all the 34 patients.There is obvious statistical difference of the standardized uptake value(SUV) between the efficacy group and the inefficacy group after treatment of 6 courses at least in 25 patients among all the 34 patients( P =0.009).There is obvious statistical difference of the SUV value before and after treatment in 8 patients among all the 34 patients(P =0.000).There is obvious statistical difference in the survival time between the efficacy group and the inefficacy group after treatment of 6 courses at least in 25 patients among all the 34 patients( P =0.015 ).Conclusions 18F-FDG PET/CT imaging plays an very important role in guiding clinical restaging,evaluating the treatment outcome,monitoring relapse and predicting prognosis of T-cell lymphoma. It is helpful to establish personalized treatment planning.